Skip to main content
. Author manuscript; available in PMC: 2026 Apr 13.
Published before final editing as: Hepatology. 2025 Dec 17:10.1097/HEP.0000000000001644. doi: 10.1097/HEP.0000000000001644

Table 6:

Indications for Dual Organ Transplant Consideration

Heart  • Congenital Heart Disease
  ∘ Fontan Associated Liver Disease (FALD)
 • Non-congenital heart disease with non-cardiac cirrhosis (e.g. alcohol, hepatitis C)
 • Transthyretin cardiac amyloidosis
 • Separate liver and heart pathologies
Kidney  • Chronic Kidney Disease from alternative diagnosis
 • Acute Renal Failure not expected to resolve post liver transplant
 • Metabolic Disorders
Lung  • Cystic Fibrosis
 • Alpha-1-antitrypsin
 • Separate liver and lung etiologies
Multivisceral  • Anatomical preclusions (Grade IV Portal Vein Thrombosis)